Cancer Research And Biostatistics is located in Seattle, WA. The organization was established in 1998. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Cancer Research And Biostatistics employed 87 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cancer Research And Biostatistics is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Cancer Research And Biostatistics generated $11.6m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 1.1% each year. All expenses for the organization totaled $11.8m during the year ending 12/2021. While expenses have increased by 1.0% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
CANCER RESEARCH AND BIOSTATISTICS (CRAB) IS A NON-PROFIT ORGANIZATION WHOSE PURPOSE IS TO HELP CONQUER CANCER AND OTHER DISEASES THROUGH THE APPLICATION OF BIOSTATISTICAL
Describe the Organization's Program Activity:
Part 3 - Line 4a
CANCER RESEARCH & BIOSTATISTICS (CRAB) IS A NATIONAL LEADER IN DESIGNING AND MANAGING ONCOLOGY CLINICAL TRIALS. CRAB IS THE STATISTICAL CENTER FOR SWOG (THE LARGEST NCI COOPERATIVE GROUP). IT IS CRABS GOAL TO PROVIDE SUPPORT AND STATISTICAL CONSULTATION FOR STUDY DESIGN, PROTOCOL DEVELOPMENT, RESEARCH DATA ANALYSIS, MANUSCRIPT WRITING, AND PRESENTATIONS AT MAJOR CONFERENCES IN ONCOLOGY RESEARCH. CRAB VALUES THE LONG-STANDING RELATIONSHIPS THAT IT HAS WITH ORGANIZATIONS TO WORK, SUPPORT AND DISCOVER NEW AND IMPROVED TREATMENTS FOR CANCER PATIENTS AND CONTINUES TO MAKE RESEARCH ALLIANCES WITH LEADING RESEARCH CONSORTIA, CANCER CENTERS, AND INDUSTRY. CRAB IS THE LEADER OF THE PANCREATIC CANCER RESEARCH TEAM (PCRT), A CONSORTIUM OF MORE THAN 40 CLINICS WORLDWIDE ESTABLISHED FOR BIOTECH AND PHARMACEUTICAL COMPANIES LOOKING TO DEVELOP NEW AGENTS FOR PATIENTS WITH PANCREAS CANCER.
IN 2021, CRAB CONTINUED TO PROVIDE ONGOING SUPPORT THROUGH EXCELLENT TRAINING TO YOUNG INVESTIGATORS AND CLINICAL RESEARCH ASSOCIATES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Hoering Antje Ceo/director | OfficerTrustee | 40 | $364,429 |
Goodman Keith W Vp, Chief Technology Officer | Officer | 40 | $232,042 |
Charters Williams Vp, CFO | Officer | 40 | $227,574 |
Malloy Curt Vp, Chief Operating Officer | Officer | 40 | $225,612 |
Cook Christopher J Director Of Applications Dev. | 40 | $177,319 | |
Durham Patrick G Director Of It | 40 | $163,140 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $7,080,797 |
All other contributions, gifts, grants, and similar amounts not included above | $3,039 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $7,083,836 |
Total Program Service Revenue | $4,427,339 |
Investment income | $44,842 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $70,594 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $11,626,712 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,273,144 |
Compensation of current officers, directors, key employees. | $640,811 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $5,757,675 |
Pension plan accruals and contributions | $380,152 |
Other employee benefits | $903,724 |
Payroll taxes | $554,049 |
Fees for services: Management | $0 |
Fees for services: Legal | $23,270 |
Fees for services: Accounting | $34,448 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $321,103 |
Advertising and promotion | $30,634 |
Office expenses | $300,558 |
Information technology | $425,664 |
Royalties | $0 |
Occupancy | $1,122,366 |
Travel | $1,879 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $222,230 |
Insurance | $80,130 |
All other expenses | $0 |
Total functional expenses | $11,787,377 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,460,414 |
Savings and temporary cash investments | $146,373 |
Pledges and grants receivable | $1,567,283 |
Accounts receivable, net | $753,017 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $521,244 |
Net Land, buildings, and equipment | $1,113,087 |
Investments—publicly traded securities | $2,580,202 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $300,876 |
Total assets | $8,442,496 |
Accounts payable and accrued expenses | $750,616 |
Grants payable | $0 |
Deferred revenue | $219,318 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,205,236 |
Total liabilities | $2,175,170 |
Net assets without donor restrictions | $6,267,326 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $8,442,496 |
Over the last fiscal year, we have identified 3 grants that Cancer Research And Biostatistics has recieved totaling $4,699,644.
Awarding Organization | Amount |
---|---|
Fred Hutchinson Cancer Research Center Seattle, WA PURPOSE: PUBLIC HEALTH SCIENCES | $4,699,154 |
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $440 |
Lamb Weston Charitable Foundation Eagle, ID PURPOSE: COMMUNITY SUPPORT | $50 |
Organization Name | Assets | Revenue |
---|---|---|
Cancer Research And Biostatistics Seattle, WA | $8,442,496 | $11,626,712 |
Rivkin Center For Ovarian Cancer Seattle, WA | $2,054,285 | $1,708,996 |
Cancer Ski Out Wilsonville, OR | $61,437 | $173,701 |
Ryan Hill Research Foundation Edmonds, WA | $2,849,969 | $249,913 |
Cush It To The Limit Sammamish, WA | $27,474 | $46,229 |
Treva Hoffman Foundation For Breast Cance Research And Patient Winchester, OR | $0 | $0 |
Cancer Cachexia Society Inc Issaquah, WA | $104,257 | $0 |
Prostate Cancer Treatment Center Foundation Edmonds, WA | $114,755 | $0 |
Betty Hise Trust For Cancer Research Salem, OR | $383,731 | $0 |
Janice Larsen Cancer Foundation Kirkland, WA | $208,833 | $21 |
Cure First Seattle, WA | $46,807 | $0 |
Endometrial Cancer Action Network For African Americans Seattle, WA | $90,237 | $0 |